The use of autologous platelet-rich plasma in the complex treatment of anal fissure combined with anal sphincter spasm in non-hospital settings
https://doi.org/10.33878/2073-7556-2022-21-1-50-58
Abstract
AIM: to evaluate the clinical efficiency of autologous platelet-rich plasma (PRP) therapy in outpatient treatment of chronic anal fissure combined with anal sphincter spasm.
PATIENTS AND METHODS: a comparative study included 480 patients with chronic anal fissure combined with anal sphincter spasm. Before excision of the anal fissure with a radiosurgical scalpel at the first stage of treatment, standard conservative treatment was performed in 220 patients (group I) and PRP therapy was used in 260 patients (group II) by injecting autologous platelet-rich plasma under the scar tissue of the fissure and into the anal sphincter. The tone of the anal sphincter was evaluated by sphincterometry.
RESULTS: after surgery, the pain was less intensive in group II than in group I patients, increased tone of anal sphincter was eliminated, quality of life and working capacity were restored, and the period of epithelization of the anal canal wound reduced (29.4 ±2.8 days versus 40.6 ±4.5 days). The recurrence rate decreased from 17.7% to 7.3%.
CONCLUSION: the use of PRP therapy in combination with excision of the anal fissure gives good results in 90.4% of patients.
About the Authors
B. M. Belik
Federal State Budgetary Educational Institution of higher Education “Rostov State Medical University” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Boris M. Belik — Head of the Department of General Surgery, Federal State Budgetary Educational Institution of higher Education “Rostov State Medical University” of the Ministry of Health of the Russian Federation; Municipal budgetary health care institution “City Hospital No. 1 named after N.A. Semashko “, Department of General Surgery
344000, Rostov-on-Don, Voroshilovsky pr.,105
Tel.: 8-904-500-64-42;
A. N. Kovalev
Federal State Budgetary Educational Institution of higher Education “Rostov State Medical University” of the Ministry of Health of the Russian Federation; “International Medical Center “URO-PRO”
Russian Federation
Russian Federation
Aleksey N. Kovalev — Assistant of the Department of General Surgery, Federal State Budgetary Educational Institution of higher Education “Rostov State Medical University” of the Ministry of Health of the Russian Federation; Surgeon of the “International Medical Center “URO-PRO”
344000, Rostov-on-Don, Voroshilovsky pr.,105
350062, Krasnodar, str. im. Yana Poluyan, build. 51/1
References
1. Adamova Z, Slovacek R, Bar T. Anal fissure. Cas Lek Cesk. 2015;154(1):11–13.
2. Vorobyev G.I. Fundamentals of coloproctology. Moscow: LLC “Medical Information Agency”. 2006; 432 p. (in Russ.).
3. Shelygin Yu.A. Clinical recommendations. Coloproctology. Edited by a akad. of RAS Shelygin Yu.A. Moscow: GEOTAR-Media. 2020; pp. 12-29. (in Russ.).
4. Breen E, Bleday R. Anal fissure: Clinical manifestations, diagnosis, prevention. Waltham, MA, 2015; pp. 11-16
5. Opazo A, Aguirre E, Saldaña E, et al. Patterns of impaired internal anal sphincter activity in patients with anal fissure. Colorectal Dis. 2013;15(4):492–499.
6. Groshilin B.C. The efficiency of using a solution of glycerin trinitrate in patients with anal fissures. Bulletin of the National Medical and Surgical Center in the name of N. I. Pirogov. 2008;3(1):58–59.
7. Tkalich O.V., Ponomarenko A.A., Fomenko O.Yu. et al. The immediate results of complex treatment of chronic anal fissure with the use of botulinum toxin type A. Koloproktologia. 2020;19(1):80–99. (in Russ.). DOI:10.33878/2073-7556-2020-19-1-80-99
8. Bobkiewicz A, Francuzik W, Krokowicz L. Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose Dependent Efficiency? A Meta-Analysis. World J Surg. 2016;40(12):3064–3072. DOI:10.1007/s00268-016-3693-9
9. Katsinelos P, Kountouras J, Paroutoglou G, et al. Aggressive treatment of acute anal fissure with 0,5% nifedipine ointment prevents its evolution to chronicity. World J Gastroenterol. 2006;12(38):6203–6206.
10. Kirkil C. The efficiency of various doses of topical isosorbide dinitrate in the treatment of chronic anal fissure and the long-term results: A prospective, randomized and controlled clinical trial. Turk J Gastroenterol. 2012;23(1):28–32.
11. Lin JX, Krishna S, Su’a B. Optimal Dosing of Botulinum Toxin for Treatment of Chronic Anal Fissure: A Systematic Review and MetaAnalysis. Dis Colon Rectum. 2016;59(9):886–894. DOI:10.1097/DCR.0000000000000612
12. Mentes BB, et al. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure. Dis Colon Rectum. 2003;46:232–237.
13. Rivkin V.L., Fine S.N., Bronstein A.S. et al. Guide to coloproctology. Moscow. 2004; 488 p. (in Russ.).
14. Nelson R, Thomas K, Morgan J, et al. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012; 2, CD003431.
15. Shelygin Yu.A. et al. Anal fissure in adults. Clinical recommendations. Moscow: 2016; pp. 8-10. (in Russ.).
16. Davies I, Dafydd L, Davies L. Long term outcomes after lateral anal sphincterotomy for anal fissure: a retrospective cohort study. Surg Today. 2014;44(6):1032–1039
17. Tkalich O.V., Zharkov E.E., Ponomarenko A.A. Modern methods of drug relaxation of the intrinsic sphincter in patients with anal fissure. Surgeon. 2019;8:26–42. (in Russ.).
18. Shelygin Yu.A., Frolov S.A., Orlova L.P. et al. Anorectal incontinence in patients who have underwent excision of the anal fissure in combination with collateral subcutaneous sphincterotomy. Koloproktologia. 2008;3(25):18–24. (in Russ.).
19. Ebinger SM, Hardt J, Warschkow R. Operative and medical treatment of chronic anal fissures-a review and network meta-analysis of randomized controlled trials. J Gastroenterol. 2017;52(6):663–676. DOI:10.1007/s00535-017-1335-0.
20. Motie MR, Hashemi P. Chronic anal fissure: a comparative study of medical treatment versus surgical sphincterotomy. Acta Med Iran. 2016;54(7):437–440.
21. Stewart D, Gaertner W, Glasgow S. Clinical practice guideline for the management of anal fissures. Dis Colon Rectum. 2017;60(1):7–14.
22. Krylov N.N. Chronic anal fissure. Bulletin of Surgical Gastroenterology. 2008;1:5–11. (in Russ.).
23. Garg P, Garg M, Menon GR. Prolonged violation of abstinence after lateral internal sphincterotomy for chronic anal fissure. Systematic review and meta-analysis. Colorectal Dis. 2013;15:e104–117.
24. Malanin D.A., Tregubov A.S., Demeshchenko M.V. et al. PRPtherapy for osteoarthritis of major joints. Volgograd.: Publishing house of VolgSMU. 2018; 49 p. (in Russ.).
25. Filardo G, Di Matteo B, Kon E, et al. Platelet-rich plasma in tendon-related disorders: results and indication. Knee Surg Sports Traumatol Arthrosc. 2018;26:1984–1999.
26. Anitua E, Sánchez M, Orive G, et al. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007;28(31):4551–4560. DOI:10.1016/j.biomaterials.2007.06.037.
27. Xuetao X, Changqing Z, Rocky S. Tuan. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2013;16(1): 204. DOI:10.1186/ar4493
28. Behera P, Behera P, Patel S, et al. Orthobiologics and platelet rich plasma. Indian J Orthop. 2014;48(1):1–9. DOI:10.4103/0019-5413.125477
29. Medvedev V.L., Opolsky A.M., Kogan M.I. Prospects for the development of regenerative technologies. Modern knowledge about platelet-enriched autoplasm and the possibility of its use in the treatment of urological diseases. Kuban Scientific Medical Bulletin. 2018;25(3):155–161. (In Russ.) DOI:10.25207/1608-6228-2018-25-3-155-161
Review
For citations:
Belik B.M., Kovalev A.N. The use of autologous platelet-rich plasma in the complex treatment of anal fissure combined with anal sphincter spasm in non-hospital settings. Koloproktologia. 2022;21(1):50-59. (In Russ.) https://doi.org/10.33878/2073-7556-2022-21-1-50-58
Views:
1667
Email this article 
